Metabolomics for mitochondrial and cancer studies

Deepak Nagrath, Christine Caneba, Thasni Karedath Abdul Azis, Nadege Bellance

Research output: Contribution to journalReview article

43 Citations (Scopus)

Abstract

Metabolomics, a high-throughput global metabolite analysis, is a burgeoning field, and in recent times has shown substantial evidence to support its emerging role in cancer diagnosis, cancer recurrence, and prognosis, as well as its impact in identifying novel cancer biomarkers and developing cancer therapeutics. Newly evolving advances in disease diagnostics and therapy will further facilitate future growth in the field of metabolomics, especially in cancer, where there is a dire need for sensitive and more affordable diagnostic tools and an urgency to develop effective therapies and identify reliable biomarkers to predict accurately the response to a therapy. Here, we review the application of metabolomics in cancer and mitochondrial studies and its role in enabling the understanding of altered metabolism and malignant transformation during cancer growth and metastasis. The recent developments in the area of metabolic flux analysis may help to close the gap between clinical metabolomics research and the development of cancer metabolome. In the era of personalized medicine with more and more patient specific targeted therapies being used, we need reliable, dynamic, faster, and yet sensitive biomarkers both to track the disease and to develop and evolve therapies during the course of treatment. Recent advances in metabolomics along with the novel strategies to analyze, understand, and construct the metabolic pathways opens this window of opportunity in a very cost-effective manner. This article is part of a Special Issue entitled: Bioenergetics of Cancer.

Original languageEnglish
Pages (from-to)650-663
Number of pages14
JournalBiochimica et Biophysica Acta - Bioenergetics
Volume1807
Issue number6
DOIs
Publication statusPublished - 1 Jun 2011
Externally publishedYes

Fingerprint

Metabolomics
Biomarkers
Neoplasms
Therapeutics
Tumor Biomarkers
Metabolites
Metabolism
Metabolic Flux Analysis
Medicine
Precision Medicine
Metabolome
Throughput
Fluxes
Growth
Metabolic Networks and Pathways
Energy Metabolism
Costs
Neoplasm Metastasis
Costs and Cost Analysis
Recurrence

Keywords

  • Cancer metabolism
  • Metabolic footprinting
  • Metabolic profiling
  • Metabolomics
  • Mitochondrial bioenergetics

ASJC Scopus subject areas

  • Biophysics
  • Biochemistry
  • Cell Biology

Cite this

Metabolomics for mitochondrial and cancer studies. / Nagrath, Deepak; Caneba, Christine; Karedath Abdul Azis, Thasni; Bellance, Nadege.

In: Biochimica et Biophysica Acta - Bioenergetics, Vol. 1807, No. 6, 01.06.2011, p. 650-663.

Research output: Contribution to journalReview article

Nagrath, Deepak ; Caneba, Christine ; Karedath Abdul Azis, Thasni ; Bellance, Nadege. / Metabolomics for mitochondrial and cancer studies. In: Biochimica et Biophysica Acta - Bioenergetics. 2011 ; Vol. 1807, No. 6. pp. 650-663.
@article{3c036102f7014c328533273882029aaa,
title = "Metabolomics for mitochondrial and cancer studies",
abstract = "Metabolomics, a high-throughput global metabolite analysis, is a burgeoning field, and in recent times has shown substantial evidence to support its emerging role in cancer diagnosis, cancer recurrence, and prognosis, as well as its impact in identifying novel cancer biomarkers and developing cancer therapeutics. Newly evolving advances in disease diagnostics and therapy will further facilitate future growth in the field of metabolomics, especially in cancer, where there is a dire need for sensitive and more affordable diagnostic tools and an urgency to develop effective therapies and identify reliable biomarkers to predict accurately the response to a therapy. Here, we review the application of metabolomics in cancer and mitochondrial studies and its role in enabling the understanding of altered metabolism and malignant transformation during cancer growth and metastasis. The recent developments in the area of metabolic flux analysis may help to close the gap between clinical metabolomics research and the development of cancer metabolome. In the era of personalized medicine with more and more patient specific targeted therapies being used, we need reliable, dynamic, faster, and yet sensitive biomarkers both to track the disease and to develop and evolve therapies during the course of treatment. Recent advances in metabolomics along with the novel strategies to analyze, understand, and construct the metabolic pathways opens this window of opportunity in a very cost-effective manner. This article is part of a Special Issue entitled: Bioenergetics of Cancer.",
keywords = "Cancer metabolism, Metabolic footprinting, Metabolic profiling, Metabolomics, Mitochondrial bioenergetics",
author = "Deepak Nagrath and Christine Caneba and {Karedath Abdul Azis}, Thasni and Nadege Bellance",
year = "2011",
month = "6",
day = "1",
doi = "10.1016/j.bbabio.2011.03.006",
language = "English",
volume = "1807",
pages = "650--663",
journal = "Biochimica et Biophysica Acta - Bioenergetics",
issn = "0005-2728",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - Metabolomics for mitochondrial and cancer studies

AU - Nagrath, Deepak

AU - Caneba, Christine

AU - Karedath Abdul Azis, Thasni

AU - Bellance, Nadege

PY - 2011/6/1

Y1 - 2011/6/1

N2 - Metabolomics, a high-throughput global metabolite analysis, is a burgeoning field, and in recent times has shown substantial evidence to support its emerging role in cancer diagnosis, cancer recurrence, and prognosis, as well as its impact in identifying novel cancer biomarkers and developing cancer therapeutics. Newly evolving advances in disease diagnostics and therapy will further facilitate future growth in the field of metabolomics, especially in cancer, where there is a dire need for sensitive and more affordable diagnostic tools and an urgency to develop effective therapies and identify reliable biomarkers to predict accurately the response to a therapy. Here, we review the application of metabolomics in cancer and mitochondrial studies and its role in enabling the understanding of altered metabolism and malignant transformation during cancer growth and metastasis. The recent developments in the area of metabolic flux analysis may help to close the gap between clinical metabolomics research and the development of cancer metabolome. In the era of personalized medicine with more and more patient specific targeted therapies being used, we need reliable, dynamic, faster, and yet sensitive biomarkers both to track the disease and to develop and evolve therapies during the course of treatment. Recent advances in metabolomics along with the novel strategies to analyze, understand, and construct the metabolic pathways opens this window of opportunity in a very cost-effective manner. This article is part of a Special Issue entitled: Bioenergetics of Cancer.

AB - Metabolomics, a high-throughput global metabolite analysis, is a burgeoning field, and in recent times has shown substantial evidence to support its emerging role in cancer diagnosis, cancer recurrence, and prognosis, as well as its impact in identifying novel cancer biomarkers and developing cancer therapeutics. Newly evolving advances in disease diagnostics and therapy will further facilitate future growth in the field of metabolomics, especially in cancer, where there is a dire need for sensitive and more affordable diagnostic tools and an urgency to develop effective therapies and identify reliable biomarkers to predict accurately the response to a therapy. Here, we review the application of metabolomics in cancer and mitochondrial studies and its role in enabling the understanding of altered metabolism and malignant transformation during cancer growth and metastasis. The recent developments in the area of metabolic flux analysis may help to close the gap between clinical metabolomics research and the development of cancer metabolome. In the era of personalized medicine with more and more patient specific targeted therapies being used, we need reliable, dynamic, faster, and yet sensitive biomarkers both to track the disease and to develop and evolve therapies during the course of treatment. Recent advances in metabolomics along with the novel strategies to analyze, understand, and construct the metabolic pathways opens this window of opportunity in a very cost-effective manner. This article is part of a Special Issue entitled: Bioenergetics of Cancer.

KW - Cancer metabolism

KW - Metabolic footprinting

KW - Metabolic profiling

KW - Metabolomics

KW - Mitochondrial bioenergetics

UR - http://www.scopus.com/inward/record.url?scp=79955625075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955625075&partnerID=8YFLogxK

U2 - 10.1016/j.bbabio.2011.03.006

DO - 10.1016/j.bbabio.2011.03.006

M3 - Review article

VL - 1807

SP - 650

EP - 663

JO - Biochimica et Biophysica Acta - Bioenergetics

JF - Biochimica et Biophysica Acta - Bioenergetics

SN - 0005-2728

IS - 6

ER -